Biogen (BIIB) EPS (Diluted) (2009 - 2026)
Biogen's EPS (Diluted) was $0.66 in Q2 2026, down 84.8% from $4.33 a year earlier and down 69.5% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EPS (Diluted) (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Biogen's EPS (Diluted) was $5.61 through Jun 30, 2026, down 46.2% year-over-year; for FY2025, it was $8.79, down 21.4% from FY2024.
- EPS (Diluted) shows a five-year compound annual growth rate of -18.7% (FY2020 to FY2025).
- In earlier years, EPS (Diluted) was $11.19 in FY2024 (+40.3%), $7.97 in FY2023 (-61.8%), $20.87 in FY2022 (+100.6%) and $10.40 in FY2021 (-58.1%).
- Quarterly EPS (Diluted) has moved between -$0.47 (Q3 2023) and $7.84 (Q3 2022) over five years.
- Compared with a year earlier, EPS (Diluted) was higher in four of the last six quarters, with an average decline of 9.8%.
- The best year-over-year quarter for EPS (Diluted) over five years was Q3 2022 (growth of 253.7%); the worst was Q2 2026 (a decline of 84.8%).
- Per Business Quant data, BIIB's EPS (Diluted) in the three quarters before Q2 2026 was $2.15 (Q1 2026), -$0.33 (Q4 2025) and $3.17 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,039.78 Bn | 1,008.37 Bn | 19.71 Bn | 7.94 |
| 2 | Johnson & Johnson | 598.09 Bn | 516.62 Bn | 17.26 Bn | 2.27 |
| 3 | AbbVie | 485.25 Bn | 458.37 Bn | 12.70 Bn | 2.04 |
| 4 | Merck | 350.07 Bn | 304.45 Bn | 12.21 Bn | -0.54 |
| 5 | Novartis Ag | 276.00 Bn | 239.99 Bn | 11.24 Bn | 1.67 |
| 6 | Astrazeneca | 241.60 Bn | 215.28 Bn | 12.86 Bn | 1.60 |
| 7 | Amgen | 222.93 Bn | 178.33 Bn | 7.24 Bn | 4.37 |
| 8 | Gilead Sciences | 183.81 Bn | 158.01 Bn | 6.22 Bn | -8.44 |
| 9 | Pfizer | 161.60 Bn | 108.24 Bn | 10.94 Bn | -0.04 |
| 10 | Biogen | 33.84 Bn | 20.49 Bn | 1.96 Bn | 0.66 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.66 |
| Mar 31, 2026 | 2.15 |
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | 3.17 |
| Jun 30, 2025 | 4.33 |
| Mar 31, 2025 | 1.64 |
| Dec 31, 2024 | 1.83 |
| Sep 30, 2024 | 2.66 |
| Jun 30, 2024 | 4.00 |
| Mar 31, 2024 | 2.70 |
| Dec 31, 2023 | 1.71 |
| Sep 30, 2023 | -0.47 |
| Jun 30, 2023 | 4.07 |
| Mar 31, 2023 | 2.67 |
| Dec 31, 2022 | 3.77 |
| Sep 30, 2022 | 7.84 |
| Jun 30, 2022 | 7.24 |
| Mar 31, 2022 | 2.06 |
| Dec 31, 2021 | 2.46 |
| Sep 30, 2021 | 2.22 |
API Access
Biogen EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();